Company intelligence / Profile preview

Esperto Medical

Irvine or Orange, California, United Statesesperto.health ↗

Ownership: Private
Development stage: Preclinical

Overview

Esperto’s Resonance Sonomanometry™ has demonstrated initial clinical validation in humans for accurate, calibration-free, continuous noninvasive blood pressure measurement. The method has been published in PNAS Nexus. The company is currently advancing toward productization and broader clinical trials with support from recent Series A funding.

Therapeutic areas: OtherCardiovascularWomen's Health
Modalities: DeviceNoninvasive diagnostic technology
Industry: Physiological Monitoring

Partnerships

Catalyst Health VenturesBold Capital PartnersWavemaker Three-sixty HealthFree Flow VenturesFund@CaltechMaverick VenturesBill & Melinda Gates Foundation

Beyond the preview

Go deeper on Esperto Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esperto Medical.

Explore the full profile